FAIR VALUE MEASUREMENT (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 04, 2025 |
Sep. 30, 2025 |
Mar. 31, 2025 |
[1] | Jun. 30, 2024 |
Mar. 31, 2024 |
[2] | Sep. 30, 2025 |
Dec. 31, 2024 |
|||||
| FairValueDisclosuresLineItem [Line Items] | |||||||||||||
| Common stock consideration payable | $ 21,028,000 | ||||||||||||
| Number of shares issued, value | $ 891,000 | $ 825,000 | $ 25,070,000 | ||||||||||
| Consideration payable | $ 11,701,000 | $ 9,238,000 | |||||||||||
| Warrant description | Of the 3,898,177 shares of common stock issuable upon exercise of the warrants, (i) 1,470,588 shares will vest and become exercisable upon the Company’s common stock achieving a last reported sale price its principal trading market equal to or greater than $1.70 for seven consecutive trading days, (ii) 1,190,476 shares will vest and become exercisable upon the Company’s common stock achieving a last reported sale price its principal trading market equal to or greater than $2.10 for seven consecutive trading day, and (iii) 1,237,113 shares will vest and become exercisable upon the Company’s common stock achieving a last reported sale price its principal trading market equal to or greater than $4.85 for seven consecutive trading days | ||||||||||||
| Envoy Technologies, Inc. [Member] | Merger Agreement [Member] | |||||||||||||
| FairValueDisclosuresLineItem [Line Items] | |||||||||||||
| Number of shares issued | 9,696,882 | ||||||||||||
| Number of shares issued, value | $ 10,000,000 | $ 9,018,000 | |||||||||||
| Issued warrants to purchase common stock | 3,898,177 | 3,898,177 | |||||||||||
| Warrant exercise price | $ 0.01 | ||||||||||||
| Fair value of warrent | $ 2,772,000 | $ 2,772,000 | |||||||||||
| Consideration payable | $ 23,491 | ||||||||||||
| |||||||||||||
| X | ||||||||||
- Definition Change in fair value of consideration payable. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. No definition available.
|
| X | ||||||||||
- Definition Description of reason for issuing warrant or right. No definition available.
|
| X | ||||||||||
- Definition Fair value of the assets less the liabilities of a derivative or group of derivatives. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|